---
title: Betamethasone + Ciprofloxacin + Phenyl Mercuric Nitrate
description: >-
  This combination medication is primarily prescribed for inflammatory
  conditions of the eye and ear where bacterial infection is present or
  suspected.  Conditions include otitis externa (outer ear infection),
  particularly when inflammation is prominent, and otitis media with
  tympanostomy tubes. It...
is_banned: false
lastModified: '2025-09-22T17:22:08.202Z'
faqs:
  - q: >-
      What is the recommended dosage for Betamethasone + Ciprofloxacin + Phenyl
      Mercuric Nitrate?**


      **A:**  See Dosage section for detailed adult and pediatric
      recommendations.
    a: 'A:**  See Dosage section for detailed adult and pediatric recommendations.'
  - q: >-
      What are the primary uses of this combination medication?**


      **A:**  It is primarily used for bacterial ear and eye infections with
      associated inflammation, including otitis externa and otitis media with
      tympanostomy tubes.
    a: >-
      A:**  It is primarily used for bacterial ear and eye infections with
      associated inflammation, including otitis externa and otitis media with
      tympanostomy tubes.
  - q: >-
      What are the most common side effects?**


      **A:**  Common side effects include local reactions like burning, itching,
      and redness at the application site.
    a: >-
      A:**  Common side effects include local reactions like burning, itching,
      and redness at the application site.
  - q: >-
      Are there any contraindications to using this medication?**


      **A:** Yes. Contraindications include hypersensitivity to any of the
      components and viral infections of the outer ear canal.
    a: >-
      A:** Yes. Contraindications include hypersensitivity to any of the
      components and viral infections of the outer ear canal.
  - q: >-
      Can this medication be used during pregnancy or breastfeeding?**


      **A:** The safety of this combination during pregnancy or breastfeeding
      has not been well established.  Consult a physician to evaluate the
      benefits and potential risks.
    a: >-
      A:** The safety of this combination during pregnancy or breastfeeding has
      not been well established.  Consult a physician to evaluate the benefits
      and potential risks.
  - q: >-
      How does ciprofloxacin work in this combination?**


      **A:** Ciprofloxacin acts as an antibiotic, inhibiting bacterial DNA
      synthesis and thus preventing bacterial growth.
    a: >-
      A:** Ciprofloxacin acts as an antibiotic, inhibiting bacterial DNA
      synthesis and thus preventing bacterial growth.
  - q: >-
      What is the role of betamethasone in this medication?**


      **A:** Betamethasone reduces inflammation and associated symptoms like
      swelling, redness, and itching.
    a: >-
      A:** Betamethasone reduces inflammation and associated symptoms like
      swelling, redness, and itching.
  - q: >-
      Why is phenyl mercuric nitrate included in this combination?**


      **A:** Phenyl mercuric nitrate acts as a preservative to prevent bacterial
      contamination of the medication.
    a: >-
      A:** Phenyl mercuric nitrate acts as a preservative to prevent bacterial
      contamination of the medication.
  - q: >-
      What should I do if a dose is missed?**


      **A:** If you miss a dose, use it as soon as you remember. If it is close
      to the time of your next dose, skip the missed dose and continue with your
      regular schedule. Do not double the dose.
    a: >-
      A:** If you miss a dose, use it as soon as you remember. If it is close to
      the time of your next dose, skip the missed dose and continue with your
      regular schedule. Do not double the dose.
  - q: >-
      What are the signs of an overdose with this medication?**


      **A:** In case of an overdose, you might experience severe dizziness or an
      allergic reaction. Contact a physician immediately if such symptoms occur.
    a: >-
      A:** In case of an overdose, you might experience severe dizziness or an
      allergic reaction. Contact a physician immediately if such symptoms occur.
---
## **Usage**

This combination medication is primarily prescribed for inflammatory conditions of the eye and ear where bacterial infection is present or suspected.  Conditions include otitis externa (outer ear infection), particularly when inflammation is prominent, and otitis media with tympanostomy tubes. It is also used for corneal ulcers and bacterial conjunctivitis.

**Pharmacological Classification:**

* Ciprofloxacin: Fluoroquinolone antibiotic
* Betamethasone: Corticosteroid
* Phenyl Mercuric Nitrate: Antiseptic and preservative

**Mechanism of Action:**

This combination exerts a synergistic effect through the distinct actions of its components. Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, essential for bacterial DNA replication and cell division. Betamethasone, a corticosteroid, provides anti-inflammatory and immunosuppressive effects by binding to glucocorticoid receptors. Phenyl mercuric nitrate acts as a preservative to prevent medication contamination.

## **Alternate Names**

This combination lacks an international nonproprietary name (INN). Brand names may vary by formulation and manufacturer, including Cifbax-B Eye/Ear Drops, CIPRAZE-B, and Cipronol-D.

## **How It Works**

**Pharmacodynamics:** Ciprofloxacin disrupts bacterial DNA replication. Betamethasone modulates inflammatory responses, while phenyl mercuric nitrate provides antimicrobial action to preserve the medication.

**Pharmacokinetics:** Specific pharmacokinetic parameters vary depending on the route of administration (eye or ear drops). Absorption is typically local, with minimal systemic effects.  Metabolism and excretion details for combined usage are not readily available. Ciprofloxacin is primarily excreted renally. Betamethasone is metabolized in the liver and excreted in urine and bile.  Phenylmercuric nitrate information is limited.

**Mode of Action:** Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV. Betamethasone binds to glucocorticoid receptors. Phenyl mercuric nitrate disrupts microbial cell membranes.

**Receptor Binding, Enzyme Inhibition, or Neurotransmitter Modulation:** Betamethasone binds to glucocorticoid receptors.  Ciprofloxacin inhibits DNA gyrase and topoisomerase IV.

**Elimination Pathways:**  Ciprofloxacin is primarily eliminated renally. Betamethasone is hepatically metabolized and excreted in urine and bile.  Information about phenylmercuric nitrate excretion pathways is limited.


## **Dosage**

### **Standard Dosage**

#### **Adults:**

**Eye Drops:** 1-2 drops in the affected eye(s) every 4 hours, or as prescribed by a physician for corneal ulcers and bacterial conjunctivitis, specifically:

* **Corneal Ulcers:** Day 1: 2 drops every 15 minutes for 6 hours, then every 30 minutes; Day 2: 2 drops every hour; Days 3-14: 2 drops every 4 hours.
* **Bacterial Conjunctivitis:** Days 1-2: Apply a half-inch ribbon to the affected eye 3 times daily; Days 3-7: Apply a half-inch ribbon twice daily, or 1-2 drops every 2 hours (days 1-2) and every 4 hours (days 3-7) while awake.

**Ear Drops:**  3-4 drops instilled into the affected ear every 6-8 hours, or as directed, or up to 5 drops twice daily (4 drops per dose for 5ml bottles).

#### **Children:**

Dosage should be determined by a pediatrician.  For bacterial conjunctivitis, the guidelines mentioned above for 1-2 year old children can be followed under medical supervision.


#### **Special Cases:**

* **Elderly Patients:**  Adjustments are usually not necessary unless renal impairment is present.
* **Patients with Renal Impairment:**  Dosage modifications may be required based on the degree of impairment.
* **Patients with Hepatic Dysfunction:** No specific adjustments are typically required, but caution is advised.
* **Patients with Comorbid Conditions:** Caution in patients with diabetes, as corticosteroids can influence blood glucose levels.

### **Clinical Use Cases**

This medication is primarily used in outpatient settings for localized eye and ear infections.  Its use in settings such as intubation, surgical procedures, mechanical ventilation, ICU, or emergency situations is not typical.


### **Dosage Adjustments**

Modifications may be necessary based on renal function, hepatic function, other metabolic disorders, and other patient-specific factors.


## **Side Effects**

### **Common Side Effects:**

Temporary burning, irritation, itching, redness at the application site, unpleasant taste, headache, rash.

### **Rare but Serious Side Effects:**

Severe dizziness, allergic reactions.

### **Long-Term Effects:**

Data on chronic complications from prolonged use are limited for the combination. Prolonged or frequent use of topical corticosteroids like betamethasone can lead to increased intraocular pressure and glaucoma.


### **Adverse Drug Reactions (ADR):**

Severe allergic reactions, including anaphylaxis, angioedema.



## **Contraindications**

Hypersensitivity to any component. Viral infections of the ear canal (e.g., herpes simplex, varicella), corneal ulcer perforation.


## **Drug Interactions**

Interactions with the combination are not well documented. Individual components have established interactions: ciprofloxacin with metal cations (antacids); betamethasone with other medications that can affect blood glucose levels.  For phenyl mercuric nitrate interaction information is limited.


## **Pregnancy and Breastfeeding**

The safety of this combination during pregnancy and breastfeeding has not been established. Exercise caution and consult with a physician to weigh benefits against potential risks.



## **Drug Profile Summary**

* **Mechanism of Action:** Ciprofloxacin inhibits bacterial DNA replication. Betamethasone exerts anti-inflammatory and immunosuppressive effects. Phenyl mercuric nitrate acts as an antiseptic.
* **Side Effects:** Burning, irritation, itching, redness, unpleasant taste, headache, rash.  Rarely, severe dizziness or allergic reactions.
* **Contraindications:** Hypersensitivity, viral ear infections, corneal perforations.
* **Drug Interactions:** Limited data for the combination.  Refer to individual components (ciprofloxacin, betamethasone).
* **Pregnancy & Breastfeeding:** Safety not established. Consult physician.
* **Dosage:** Adults:  Eye/Ear drops as detailed in Dosage section. Children: Consult pediatrician.
* **Monitoring Parameters:** Observe for local reactions, signs of infection resolution, and potential systemic effects.  Monitor intraocular pressure with prolonged use.


## **Popular Combinations**

This specific three-drug combination is itself a common formulation.  There are no additional "popular combinations" beyond this.


## **Precautions**

Screen for allergies. Consider renal/hepatic function, diabetes, other medical conditions.  Caution in pregnancy and breastfeeding.  Safety and efficacy in children younger than 6 months have not been established.


## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Betamethasone + Ciprofloxacin + Phenyl Mercuric Nitrate?**

**A:**  See Dosage section for detailed adult and pediatric recommendations.

### **Q2:  What are the primary uses of this combination medication?**

**A:**  It is primarily used for bacterial ear and eye infections with associated inflammation, including otitis externa and otitis media with tympanostomy tubes.

### **Q3: What are the most common side effects?**

**A:**  Common side effects include local reactions like burning, itching, and redness at the application site.

### **Q4: Are there any contraindications to using this medication?**

**A:** Yes. Contraindications include hypersensitivity to any of the components and viral infections of the outer ear canal.

### **Q5: Can this medication be used during pregnancy or breastfeeding?**

**A:** The safety of this combination during pregnancy or breastfeeding has not been well established.  Consult a physician to evaluate the benefits and potential risks.

### **Q6: How does ciprofloxacin work in this combination?**

**A:** Ciprofloxacin acts as an antibiotic, inhibiting bacterial DNA synthesis and thus preventing bacterial growth.

### **Q7: What is the role of betamethasone in this medication?**

**A:** Betamethasone reduces inflammation and associated symptoms like swelling, redness, and itching.


### **Q8: Why is phenyl mercuric nitrate included in this combination?**

**A:** Phenyl mercuric nitrate acts as a preservative to prevent bacterial contamination of the medication.


### **Q9:  What should I do if a dose is missed?**

**A:** If you miss a dose, use it as soon as you remember. If it is close to the time of your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose.


### **Q10:  What are the signs of an overdose with this medication?**

**A:** In case of an overdose, you might experience severe dizziness or an allergic reaction. Contact a physician immediately if such symptoms occur.

